ID 415106281 · FY 2019–2024 · 6 years
საქმიანობის სფერო, რადგანაც იგი ახდენს მედიკამენეტების იმპორტს და ექსპორტს როგორც საქართველოში, ასევე საქართველოს საზღვრებს გარეთ, ისეთ ქვეყნებში როგორიცაა აზერბაიჯანი, უკრაინა, ყაზახეთი, ყირგიზეთი, თურქმენეთი, ბელორუსია, მოლდავეთი.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 1 | 10,210 | 10,827 | 11,634 | 8,083 | -285 | nmf |
| Net Cash used in Investing Activities | -0 | -9,987 | -10,951 | -11,572 | -7,911 | 0 | nmf |
| Free Cash Flow (OCF − Capex proxy) | 1 | 224 | -124 | 61 | 172 | -285 | nmf |
| Net Change in Cash (before FX) | 1 | 224 | -124 | 61 | 172 | -285 | nmf |
| Effect of FX on Cash | 0 | 0 | 0 | 0 | 0 | -43 | |
| Net Change in Cash (incl. FX) | 1 | 224 | -124 | 61 | 172 | -327 | nmf |
| Cash at Beginning of Year | 0 | 0 | 224 | 100 | 162 | 333 | +14.1% |
| Cash at End of Year | 1 | 224 | 100 | 162 | 333 | 6 | +64.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).